Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)
Rethinking Clinical Trials
DECEMBER 20, 2023
years for females at age 45 years or older. Of those who have had a first MI, the percentage with a recurrent MI or fatal CHD within 5 years is 17% of males and 21% of females age 45 years or older. Increasing diversity in trial leadership is one of the most important strategies to increase diversity among RCT participants.
169 
Let's personalize your content